Trial Profile
A Study Evaluating Quantitative Scoring Method of [18F] Flortaucipir PET Scans in Typical and Atypical Phenotypes of Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2018
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 05 Oct 2018 New trial record